Kent is co-founder of PhotoPharmics, Inc., and as CEO leads the company in its efforts to develop, validate, and market novel, non-invasive phototherapy devices. Kent most recently served as President and CEO of Apollo Light Systems, Inc. Under Kent’s leadership the Apollo team secured a portfolio of intellectual property, created and launched innovative and award-winning products, conducted and supported a myriad of successful government and privately funded human clinical trials, introduced therapies in both the medical and retail markets, and brought healing to hundreds of thousands of sleep and mood disorder patients. These successes resulted in a merger with Philips/Respironics. Kent holds a Master of Business Administration from Brigham Young University.
Dan is co-founder of PhotoPharmics, Inc., and is responsible for ongoing clinical trials at the company. Dan previously served as the Senior Application Scientist for light therapy in the USA for Philips Consumer Lifestyle. Dan was in charge of Philips chronobiology research, FDA trials and institutional KOL relationships in North America. He also managed product claims and professional marketing for Philips Vitalight Division in the USA. Prior to working with Philips, Dan was a key partner at Apollo Light Systems, Inc., and directed Apollo's research and medical marketing programs. Dan holds a Bachelor of Arts in Communications and Media from Brigham Young University.
Marc supports Regulatory Affairs, Quality, and Product Development at PhotoPharmics. He is absolutely committed to the well-being of Parkinson's patients. Previously at Aribex, Inc., Marc had responsibility for 2D imaging product management; he then led international marketing and sales, continuing with the company after acquisition by Danaher Corporation. For 30 years, he has focused on localization / globalization and also medical device compliance in developing and commercializing ground-breaking product categories. Marc was already employed in manufacturing and technical communications fields while an Engineering and Technology college undergrad. Marc holds a Bachelor of Science from Brigham Young University, and has a background in German.
Marcus brings to PhotoPharmics 35 years experience in launching and developing medical devices and consumer electronics. He led the worldwide launch of DBS for Parkinson's and Essential Tremor at Medtronic, Inc. In his 19 years at Medtronic, Marcus led product development of dual chamber implantable pacemakers and was Field Marketing Director of the European subsidiary Vitatron Medical BV, where he planned and launched seven new implantable pacemaker systems. Committed to entrepreneurship and executive development, Marcus is a Director Emeritus with the Pasadena Angels, Inc. and a CEO Coach with Vistage International. Marcus holds a Master of Science in Electrical Engineering and Computer Science from the Massachusetts Institute of Technology and a Master of Business Administration from University of Minnesota. He is passionate about helping people with Parkinson's disease enjoy fuller lives.
Matt is a highly accomplished marketing executive and brings 20 years of industry experience in the areas of both medical marketing and sales to PhotoPharmics. Matt has played a lead role in the commercialization of multiple products and line extensions in the areas of pain management / supportive care, women's health, diagnostic imaging and radiopharmaceuticals. At Cephalon (Teva Pharmaceuticals), Matt led the launch of pain products and had responsibility for KOL relationships. Prior to that, Matt led product launches at Berlex Laboratories (Bayer) and completed a corporate development rotation at parent company Schering, AG (Berlin, Germany). Matt holds a Bachelor of Science from Shippensburg University and a Master of Business Administration from St. Joseph's University.